Long-term efficacy and safety of ustekinumab, with and without dosing adjustment, in patients with moderate-to-severe psoriasis: Results from the PHOENIX 2 study through 5 years of follow-up

R. G. Langley, M. Lebwohl, G. G. Krueger, P. O. Szapary, Y. Wasfi, D. Chan, M. C. Hsu, Y. You, Y. Poulin, N. Korman, J. C. Prinz, K. Reich

科研成果: 期刊稿件 › 文章 › 同行评审

163 引用 （Scopus）

指纹

探究 'Long-term efficacy and safety of ustekinumab, with and without dosing adjustment, in patients with moderate-to-severe psoriasis: Results from the PHOENIX 2 study through 5 years of follow-up' 的科研主题。它们共同构成独一无二的指纹。

Pharmacology, Toxicology and Pharmaceutical Science

Neuroscience

Biochemistry, Genetics and Molecular Biology

Keyphrases